Biotech

Latest Articles

Kailera launches with $400M series A, 4 Chinese obesity drugs

.Kailera Therapies has launched in to the more and more jampacked weight problems area with a collec...

Metsera partner with Amneal to lock down GLP-1 supply

.Along with early phase 1 information now out in the wild, metabolic health condition ensemble Metse...

Rivus posts records to back up muscle-sparing being overweight medicine cases

.Rivus Pharmaceuticals has revealed the data behind its own stage 2 excessive weight succeed in card...

BMS spends $110M to create T-cell treatment deal, assisting Top acquire opportunity to develop prioritized pipe

.Bristol Myers Squibb is actually paying Perfect Medication $110 thousand in advance to develop reag...

Generate gains another $1B-plus Big Pharma relationship

.Novartis has actually printer inked a deal possibly worth more than $1 billion along with Flagship-...

Metsera GLP-1 information slice discloses 7.5% weight management at 36 days

.Recently debuted Metsera is unfolding some period 1 data for its own GLP-1 receptor agonist, uncove...

Flagship wishes biotechs flock to Mirai to improve genetic meds

.In the middle of the genetic medicines arms race, Front runner Pioneering is introducing a brand ne...

BioAge eyes $180M from IPO, personal positioning for being overweight tests

.BioAge Labs is actually checking out about $180 million in initial earnings from an IPO and an excl...

Merck's LAG-3 combo fails colon cancer cells period 3 research study

.A try by Merck &amp Co. to open the microsatellite stable (MSS) metastatic colon cancer market has ...

Spanish VC closes $200M lifestyle scientific researches fund

.Spain-based Asabys Allies has actually closed a fund of 180 thousand europeans ($ 200 thousand), ca...

BioAge generates $198M from IPO as weight problems biotech joins Nasdaq

.BioAge Labs is generating almost $200 million by means of its Nasdaq IPO this morning, along with t...

Acadia delivers BMS vet aboard as chief executive officer-- Chutes &amp Ladders

.Invite to today's Chutes &amp Ladders, our summary of notable management hirings, firings and retir...

Cassava pays $40M over supposedly misleading Alzheimer's update

.Cassava Sciences has accepted spend $40 million to settle an investigation into insurance claims it...

Merck bags possibilities on Evaxion's AI-designed injection candidates

.Merck &amp Co. has actually gotten options on 2 Evaxion Biotech vaccine applicants, spending $3.2 t...

Enanta's RSV antiviral crushes virus-like tons in challenge research

.Enanta Pharmaceuticals has actually connected its own respiratory syncytial infection (RSV) antivir...

Biogen containers SAGE-324 cooperation after essential tremor fail

.Biogen has provided the final ceremonies to its partnership along with Sage Therapies on SAGE-324, ...

AbbVie Parkinson's drug coming from $8.7 B Cerevel buyout credit ratings

.On the very same time that some Parkinson's health condition medications are being actually called ...

Arch finalizes $3B-plus fund to cultivate biopharma upstarts

.On the heels of a $3 billion fund from Bain Capital Life Sciences, Arch Venture Allies is actually ...

Orion to utilize Aitia's 'electronic doubles' to find new cancer cells drugs

.Finnish biotech Orion has actually snooped possible in Aitia's "digital twin" tech to build brand-n...

Windtree's shock med brings up high blood pressure in most current period 2 win

.While Windtree Rehabs has had a hard time to develop the monetary roots needed to survive, a period...